Robert Cherill

2.2k total citations · 1 hit paper
10 papers, 1.6k citations indexed

About

Robert Cherill is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Robert Cherill has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Dermatology, 8 papers in Immunology and Allergy and 2 papers in Physiology. Recurrent topics in Robert Cherill's work include Dermatology and Skin Diseases (9 papers), Allergic Rhinitis and Sensitization (7 papers) and Food Allergy and Anaphylaxis Research (4 papers). Robert Cherill is often cited by papers focused on Dermatology and Skin Diseases (9 papers), Allergic Rhinitis and Sensitization (7 papers) and Food Allergy and Anaphylaxis Research (4 papers). Robert Cherill collaborates with scholars based in Switzerland, United States and Canada. Robert Cherill's co-authors include Michael Graeber, Jon M. Hanifin, Mitsuyoshi Omoto, S.J. Tofte, C. Paul, Kim Papp, Y. De Prost, Ulrich Wahn, R. Caputo and Thomas Hultsch and has published in prestigious journals such as PEDIATRICS, The Journal of Pediatrics and British Journal of Dermatology.

In The Last Decade

Robert Cherill

10 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

2001 874 citations Jon M. Hanifin, Mitsuyoshi Omoto et al. Experimental Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Cherill Switzerland	9	1.5k	1.2k	396	128	110	10	1.6k
Julie Block United States	8	1.3k 0.8×	996 0.8×	473 1.2×	99 0.8×	152 1.4×	10	1.4k
R. Chopra United States	18	1.0k 0.7×	882 0.7×	416 1.1×	49 0.4×	86 0.8×	34	1.1k
A. Gadkari United States	8	1.3k 0.8×	1.0k 0.8×	542 1.4×	104 0.8×	221 2.0×	25	1.3k
Finn Schultz Larsen Denmark	12	1.1k 0.7×	957 0.8×	475 1.2×	113 0.9×	57 0.5×	21	1.3k
Jon M. Hanifin United States	8	660 0.4×	514 0.4×	211 0.5×	104 0.8×	71 0.6×	11	799
S.J. Tofte United States	5	965 0.6×	804 0.7×	328 0.8×	63 0.5×	83 0.8×	5	1.0k
A. Fink‐Wagner Germany	5	927 0.6×	749 0.6×	316 0.8×	66 0.5×	118 1.1×	7	990
J Ring Germany	6	807 0.5×	642 0.5×	293 0.7×	92 0.7×	57 0.5×	14	946
S. Auziere United Kingdom	6	823 0.5×	671 0.5×	336 0.8×	71 0.6×	103 0.9×	11	918
L. Labrèze France	4	746 0.5×	620 0.5×	295 0.7×	73 0.6×	39 0.4×	13	936

Countries citing papers authored by Robert Cherill

Since Specialization

Citations

This map shows the geographic impact of Robert Cherill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cherill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cherill more than expected).

Fields of papers citing papers by Robert Cherill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cherill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cherill. The network helps show where Robert Cherill may publish in the future.

Co-authorship network of co-authors of Robert Cherill

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cherill. A scholar is included among the top collaborators of Robert Cherill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cherill. Robert Cherill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Langley, Richard G., Lawrence F. Eichenfield, Anne W. Lucky, et al.. (2008). Sustained Efficacy and Safety of Pimecrolimus Cream 1% when Used Long‐term (up to 26 Weeks) to Treat Children with Atopic Dermatitis. Pediatric Dermatology. 25(3). 301–307. 29 indexed citations

2.

Wolff, K., Colin Fleming, Jon M. Hanifin, et al.. (2005). Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. British Journal of Dermatology. 152(6). 1296–1303. 30 indexed citations

3.

Gottlieb, Alice B., C.E.M. Griffiths, Vincent Ho, et al.. (2005). Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. British Journal of Dermatology. 152(6). 1219–1227. 43 indexed citations

4.

Barbier, Nathalie, C. Paul, Thomas A. Luger, et al.. (2004). Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. British Journal of Dermatology. 150(1). 96–102. 121 indexed citations

5.

Belsito, D., Joseph F. Fowler, James G. Marks, et al.. (2004). Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.. PubMed. 73(1). 31–8. 63 indexed citations

6.

Ho, Vincent, Aditya K. Gupta, Roland Kaufmann, et al.. (2003). Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. The Journal of Pediatrics. 142(2). 155–162. 151 indexed citations

7.

Wahn, Ulrich, Jan D. Bos, Mark Goodfield, et al.. (2002). Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children. PEDIATRICS. 110(1). e2–e2. 280 indexed citations

8.

Hebert, Adelaide A., et al.. (2001). Pimecrolimus cream 1%: A new development in nonsteroid topical treatment of inflammatory skin diseases. Seminars in Cutaneous Medicine and Surgery. 20(4). 260–267. 25 indexed citations

9.

Hanifin, Jon M., et al.. (2001). The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 10(1). 11–18. 874 indexed citations breakdown →

10.

Bush, Christopher, et al.. (2001). SDZ ASM 981 cream 1% is effective and safe in children and adolescents with atopic dermatitis. Clinical and Experimental Dermatology. 26(2). 214–215. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact